Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 17, 2020, 7:57 p.m.

/zigman2/quotes/209129655/composite

$

20.75

Change

-0.22 -1.05%

Volume

Volume 31,391

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Previous close

$ 20.43

$ 20.97

Change

+0.54 +2.64%

Day low

Day high

$20.11

$21.90

Open

52 week low

52 week high

$15.01

$89.88

Open

Mark Castaneda

Mark Castaneda occupies the position of Chief Financial Officer & Treasurer for Tilray, Inc.nHe previously held the position of Chief Financial Officer & Assistant Treasurer at Primo Water Corp., Chief Financial Officer of Tecta America Corp., Chief Financial Officer & Secretary at Pike Corp. and Chief Financial Officer of Pike Electric LLC (a subsidiary of Pike Corp.), Chief Financial Officer for All Star Gas Corp., Chief Financial Officer & Director at Blue Rhino Corp., Chief Financial Officer at Interact Public Safety Systems, Inc. and Principal at Deloitte & Touche LLP.nMr. Castaneda received an undergraduate degree and a graduate degree from DePaul University.

Transactions

Date Shares Transaction Value
07/18/2019 78,700   Derivative/Non-derivative trans. at $43.41 per share. 3,416,367
07/18/2019 200,000   Derivative/Non-derivative trans. at $0 per share. 0
04/15/2019 10,000   Disposition at $51.72 per share. 517,200
04/15/2019 10,000   Derivative/Non-derivative trans. at $7.76 per share. 77,600
03/14/2019 30,000   Disposition at $70.43 per share. 2,112,900
03/14/2019 30,000   Derivative/Non-derivative trans. at $7.76 per share. 232,800
02/25/2019 900   Disposition at $79.38 per share. 71,442
02/25/2019 8,197   Disposition at $78.68 per share. 644,940
02/25/2019 30,903   Disposition at $77.89 per share. 2,407,035
02/25/2019 40,000   Derivative/Non-derivative trans. at $7.76 per share. 310,400
07/23/2018 6,500   Gift at $0 per share. 0
07/23/2018 14,705   Acquisition at $17 per share. 249,985

Officers and Executives

Mr. Brendan Kennedy
President, Chief Executive Officer & Director
Mr. Jon Levin
Chief Operating Officer
Mr. Greg Christopher
Executive Vice President-Operations
Mr. Mark Castaneda
Chief Financial Officer & Treasurer
Dr. Joshua Eades
Chief Science Officer & Vice President
Ms. Kristina Adamski
Executive Vice President-Corporate Affairs
Ms. Alexandra Cremonese
Manager-International Sourcing & Development
Mr. John Andonoff
SVP-Global Medical Sales Development
Mr. Charlie Cain
Vice President-Retail
Mr. Andrew Pucher
Chief Corporate Development Officer
Mr. Edward Wood Pastorius
Chief Revenue Officer
Mr. Michael B. Auerbach
Director
Ms. Adine Fabiani-Carter
Chief Marketing Officer
Ms. Katie Turner
Investors Contact
Ms. Rita Seguin
Executive Vice President-Human Resources
Ms. Dara Redler
Secretary & General Counsel
Ms. Catherine Jacobson
VP-Regulatory & Medical Affairs
Ms. Christine Thompson St. Clare
Independent Director
Ms. Maryscott Greenwood
Independent Director
Ms. Rebekah Dopp
Independent Director
Mr. Michael Shtender-Auerbach
Independent Director
Link to MarketWatch's Slice.